Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

AP News

News Summary: Fast-growing salmon in FDA limbo

STAYING AFLOAT: A Massachusetts biotech firm that was poised to become the first company to sell a genetically-modified fish says it may run out of money before regulators approve its fast-growing salmon.

FRANKENFISH: Aquabounty's Atlantic salmon contains an extra hormone that makes it to grow twice as fast as a traditional salmon. Despite concerns from environmentalists, regulators said in 2010 that the fish appeared safe to eat.

RUNNING ON EMPTY: The Food and Drug Administration says it is still working to complete its review of Aquabounty's salmon. Company executives say they only have enough money to operate the company until January.

blog comments powered by Disqus